Significance of AT1 receptor independent activation of mineralocorticoid receptor in murine diabetic cardiomyopathy

Yuji Nagatomo, Tomomi Meguro, Hiroyuki Ito, Kimi Koide, Toshihisa Anzai, Keiichi Fukuda, Satoshi Ogawa, Tsutomu Yoshikawa

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Diabetes mellitus (DM) has deleterious influence on cardiac performance independent of coronary artery disease and hypertension. The objective of the present study was to investigate the role of the renin-angiotensin-aldosterone system, especially angiotensin II type 1a receptor (AT1aR) and mineralocorticoid receptor (MR) signaling, in left ventricular (LV) dysfunction induced by diabetes mellitus (DM). Methods and Results: DM was induced by intraperitoneal injection of streptozotocin (200 mg/kg BW) in wild-type (WT) or AT1aR knockout (KO) male mice, and they were bred during 6 or 12 weeks. Some KO mice were administered the MR antagonist eplerenone (100 mg/kg body weight). At 6 weeks, LV diastolic function was impaired in WT-DM, but preserved in KO-DM. At that time point MR mRNA expression was upregulated, NADPH oxidase subunit (p47phox) and glutathione peroxidase (GPx1) mRNA expression were upregulated, the staining intensities of LV tissue for 4-hydroxy-2-nonenal was stronger in immunohistochemistry, the number of terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) positive cells was increased, Bcl-2 protein expression was significantly downregulated, and the expression of SERCA2a and phosphorylated phospholamban was depressed in WT-DM, while these changes were not seen in KO-DM. At 12 weeks, however, these changes were also noted in KO-DM. Eplerenone arrested those changes. The plasma aldosterone concentration was elevated in WT-DM but not in KO-DM at 6 weeks. It showed 3.7-fold elevation at 12 weeks even in KODM, which suggests "aldosterone breakthrough" phenomenon. However, the aldosterone content in LV tissue was unchanged in KO-DM. Conclusions: DM induced diastolic dysfunction was observed even in KO at 12 weeks, which was ameliorated by minelarocorticoid receptor antagonist, eplerenone. AT 1-independent MR activation in the LV might be responsible for the pathogenesis of diabetic cardiomyopathy.

Original languageEnglish
Article numbere93145
JournalPLoS One
Volume9
Issue number3
DOIs
Publication statusPublished - 2014 Mar 24

Fingerprint

Diabetic Cardiomyopathies
Mineralocorticoid Receptors
cardiomyopathy
Medical problems
diabetes mellitus
Diabetes Mellitus
Chemical activation
receptors
mice
aldosterone
Aldosterone
Angiotensin Type 1 Receptor
angiotensin II
Knockout Mice
mineralocorticoid receptors
antagonists
Tissue
Mineralocorticoid Receptor Antagonists
angiotensins
renin

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Significance of AT1 receptor independent activation of mineralocorticoid receptor in murine diabetic cardiomyopathy. / Nagatomo, Yuji; Meguro, Tomomi; Ito, Hiroyuki; Koide, Kimi; Anzai, Toshihisa; Fukuda, Keiichi; Ogawa, Satoshi; Yoshikawa, Tsutomu.

In: PLoS One, Vol. 9, No. 3, e93145, 24.03.2014.

Research output: Contribution to journalArticle

Nagatomo, Yuji ; Meguro, Tomomi ; Ito, Hiroyuki ; Koide, Kimi ; Anzai, Toshihisa ; Fukuda, Keiichi ; Ogawa, Satoshi ; Yoshikawa, Tsutomu. / Significance of AT1 receptor independent activation of mineralocorticoid receptor in murine diabetic cardiomyopathy. In: PLoS One. 2014 ; Vol. 9, No. 3.
@article{0658b4ca9bea4aaeaaba6cea7bb40382,
title = "Significance of AT1 receptor independent activation of mineralocorticoid receptor in murine diabetic cardiomyopathy",
abstract = "Background: Diabetes mellitus (DM) has deleterious influence on cardiac performance independent of coronary artery disease and hypertension. The objective of the present study was to investigate the role of the renin-angiotensin-aldosterone system, especially angiotensin II type 1a receptor (AT1aR) and mineralocorticoid receptor (MR) signaling, in left ventricular (LV) dysfunction induced by diabetes mellitus (DM). Methods and Results: DM was induced by intraperitoneal injection of streptozotocin (200 mg/kg BW) in wild-type (WT) or AT1aR knockout (KO) male mice, and they were bred during 6 or 12 weeks. Some KO mice were administered the MR antagonist eplerenone (100 mg/kg body weight). At 6 weeks, LV diastolic function was impaired in WT-DM, but preserved in KO-DM. At that time point MR mRNA expression was upregulated, NADPH oxidase subunit (p47phox) and glutathione peroxidase (GPx1) mRNA expression were upregulated, the staining intensities of LV tissue for 4-hydroxy-2-nonenal was stronger in immunohistochemistry, the number of terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) positive cells was increased, Bcl-2 protein expression was significantly downregulated, and the expression of SERCA2a and phosphorylated phospholamban was depressed in WT-DM, while these changes were not seen in KO-DM. At 12 weeks, however, these changes were also noted in KO-DM. Eplerenone arrested those changes. The plasma aldosterone concentration was elevated in WT-DM but not in KO-DM at 6 weeks. It showed 3.7-fold elevation at 12 weeks even in KODM, which suggests {"}aldosterone breakthrough{"} phenomenon. However, the aldosterone content in LV tissue was unchanged in KO-DM. Conclusions: DM induced diastolic dysfunction was observed even in KO at 12 weeks, which was ameliorated by minelarocorticoid receptor antagonist, eplerenone. AT 1-independent MR activation in the LV might be responsible for the pathogenesis of diabetic cardiomyopathy.",
author = "Yuji Nagatomo and Tomomi Meguro and Hiroyuki Ito and Kimi Koide and Toshihisa Anzai and Keiichi Fukuda and Satoshi Ogawa and Tsutomu Yoshikawa",
year = "2014",
month = "3",
day = "24",
doi = "10.1371/journal.pone.0093145",
language = "English",
volume = "9",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "3",

}

TY - JOUR

T1 - Significance of AT1 receptor independent activation of mineralocorticoid receptor in murine diabetic cardiomyopathy

AU - Nagatomo, Yuji

AU - Meguro, Tomomi

AU - Ito, Hiroyuki

AU - Koide, Kimi

AU - Anzai, Toshihisa

AU - Fukuda, Keiichi

AU - Ogawa, Satoshi

AU - Yoshikawa, Tsutomu

PY - 2014/3/24

Y1 - 2014/3/24

N2 - Background: Diabetes mellitus (DM) has deleterious influence on cardiac performance independent of coronary artery disease and hypertension. The objective of the present study was to investigate the role of the renin-angiotensin-aldosterone system, especially angiotensin II type 1a receptor (AT1aR) and mineralocorticoid receptor (MR) signaling, in left ventricular (LV) dysfunction induced by diabetes mellitus (DM). Methods and Results: DM was induced by intraperitoneal injection of streptozotocin (200 mg/kg BW) in wild-type (WT) or AT1aR knockout (KO) male mice, and they were bred during 6 or 12 weeks. Some KO mice were administered the MR antagonist eplerenone (100 mg/kg body weight). At 6 weeks, LV diastolic function was impaired in WT-DM, but preserved in KO-DM. At that time point MR mRNA expression was upregulated, NADPH oxidase subunit (p47phox) and glutathione peroxidase (GPx1) mRNA expression were upregulated, the staining intensities of LV tissue for 4-hydroxy-2-nonenal was stronger in immunohistochemistry, the number of terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) positive cells was increased, Bcl-2 protein expression was significantly downregulated, and the expression of SERCA2a and phosphorylated phospholamban was depressed in WT-DM, while these changes were not seen in KO-DM. At 12 weeks, however, these changes were also noted in KO-DM. Eplerenone arrested those changes. The plasma aldosterone concentration was elevated in WT-DM but not in KO-DM at 6 weeks. It showed 3.7-fold elevation at 12 weeks even in KODM, which suggests "aldosterone breakthrough" phenomenon. However, the aldosterone content in LV tissue was unchanged in KO-DM. Conclusions: DM induced diastolic dysfunction was observed even in KO at 12 weeks, which was ameliorated by minelarocorticoid receptor antagonist, eplerenone. AT 1-independent MR activation in the LV might be responsible for the pathogenesis of diabetic cardiomyopathy.

AB - Background: Diabetes mellitus (DM) has deleterious influence on cardiac performance independent of coronary artery disease and hypertension. The objective of the present study was to investigate the role of the renin-angiotensin-aldosterone system, especially angiotensin II type 1a receptor (AT1aR) and mineralocorticoid receptor (MR) signaling, in left ventricular (LV) dysfunction induced by diabetes mellitus (DM). Methods and Results: DM was induced by intraperitoneal injection of streptozotocin (200 mg/kg BW) in wild-type (WT) or AT1aR knockout (KO) male mice, and they were bred during 6 or 12 weeks. Some KO mice were administered the MR antagonist eplerenone (100 mg/kg body weight). At 6 weeks, LV diastolic function was impaired in WT-DM, but preserved in KO-DM. At that time point MR mRNA expression was upregulated, NADPH oxidase subunit (p47phox) and glutathione peroxidase (GPx1) mRNA expression were upregulated, the staining intensities of LV tissue for 4-hydroxy-2-nonenal was stronger in immunohistochemistry, the number of terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) positive cells was increased, Bcl-2 protein expression was significantly downregulated, and the expression of SERCA2a and phosphorylated phospholamban was depressed in WT-DM, while these changes were not seen in KO-DM. At 12 weeks, however, these changes were also noted in KO-DM. Eplerenone arrested those changes. The plasma aldosterone concentration was elevated in WT-DM but not in KO-DM at 6 weeks. It showed 3.7-fold elevation at 12 weeks even in KODM, which suggests "aldosterone breakthrough" phenomenon. However, the aldosterone content in LV tissue was unchanged in KO-DM. Conclusions: DM induced diastolic dysfunction was observed even in KO at 12 weeks, which was ameliorated by minelarocorticoid receptor antagonist, eplerenone. AT 1-independent MR activation in the LV might be responsible for the pathogenesis of diabetic cardiomyopathy.

UR - http://www.scopus.com/inward/record.url?scp=84899742749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899742749&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0093145

DO - 10.1371/journal.pone.0093145

M3 - Article

VL - 9

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 3

M1 - e93145

ER -